Evolent Health (EVH) Profit After Tax (2014 - 2026)

Evolent Health's Profit After Tax history runs 13 years deep, the most recent figure standing at -$26.6 million for Q1 2026.

• On a quarterly basis, Profit After Tax rose 63.13% year-over-year to -$26.6 million in Q1 2026; TTM through Mar 2026 was -$533.8 million, a 357.91% decrease from a year earlier, with the FY2025 full-year figure at -$580.3 million, down 517.64% from the prior year.
• Profit After Tax advanced to -$26.6 million in Q1 2026 per EVH's latest filing, from -$429.1 million in the prior quarter.
• Across five years, Profit After Tax topped out at $2.1 million in Q3 2022 and bottomed at -$429.1 million in Q4 2025.
• The 5-year median for Profit After Tax is -$25.3 million (2023), against an average of -$47.9 million.
• Across the five-year window, Profit After Tax soared 116.28% in 2022 and slumped 3301.13% in 2025, its largest moves.
• Year by year, Profit After Tax stood at -$11.3 million in 2022, then tumbled by 264.75% to -$41.4 million in 2023, then soared by 44.92% to -$22.8 million in 2024, then plunged by 1781.99% to -$429.1 million in 2025, then surged by 93.79% to -$26.6 million in 2026.
• Per Business Quant, the three latest EVH Profit After Tax figures stand at -$26.6 million (Q1 2026), -$429.1 million (Q4 2025), and -$26.9 million (Q3 2025).